Skip to main content
Premium Trial:

Request an Annual Quote

NextBio, Genophen Link up to Use Genomic Data for Disease Prevention and Wellness

NEW YORK (GenomeWeb News) – NextBio and Genophen today said they are partnering to drive adoption of genomics for disease prevention and wellness.

They said the deal allows Genophen to interpret genomic sequencing data from patients through the use of NextBio's clinical platform and to combine this information with data about a patient's environmental, behavioral, and clinical factors "to create a uniquely tailored disease prevention and wellness plan for its individual member."

Financial and other terms of the deal were not disclosed.

"NextBio's vast and comprehensive repository of curated genomic and clinical data from the public domain adds depth to our analysis," Hossein Fakhrai-Rad, co-founder, president, and CEO of Genophen, said in a statement. "This partnership with NextBio Clinical enables us to efficiently analyze and interpret whole-genome data."

NextBio, based in Santa Clara, Calif., provides tools for the interpretation of large amounts molecular and other life sciences data.

Genophen is headquartered in Los Altos, Calif., and has developed a software platform for assessing a patient's disease risk, providing a personalized and actionable set of recommendations, it said.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.